香蕉视频

Education

GRADUATE:
Banaras Hindu University
Degree: Doctor of Philosophy 

Banaras Hindu University
Degree: Master of Science

UNDERGRADUATE:
Banaras Hindu University
Degree: Bachelor of Science

Research Interests

Dr. Singh's research interests in cancer immunobiology, health disparity, drug discovery, precision oncology, nanotechnology, and chemokines, using in silico, in vitro, and in vivo models, contribute to multiple disciplines, including basic and translational oncology, vaccine development, and chemoprevention.

His long-term goal is to improve cancer patients' therapeutic outcomes and overall survival and train the underrepresented groups, thereby enhancing the diversity of the future biomedical workforce.

Publications

• B. Kinnel, S.K. Singh, G. Oprea-Ilies, R. Singh 2023. Targeted Therapy and Mechanisms
• of Drug Resistance in Breast Cancer. Cancers PMCID: PMC9954028.
• S. K. Singh and R. Singh 2022. Nanotherapy: Targeting the tumor microenvironment.
• Nature Reviews Cancer PMID: 35236941.
• S. Aladuwaka, R. Alagan, R. Singh, M. Mishra 2022. Health Burdens and Socioeconomic Status in Alabama: Using Geographic Information System to examine Prostate Cancer Health Disparity. Cancers PMCID: PMC9563407.
• S. Singh, N. K. Agrawal, G. Singh, S. Gehlot, S. K. Singh, R. Singh 2022. Clinical prediction of type 2 diabetes mellitus (T2DM) via anthropometric and biochemical variations in prakriti. Diseases. PMCID: PMC8947277.
• M. McFadden, S. K. Singh, G. Oprea-Ilies, and R. Singh 2021. Nano-based drug delivery and targeting to overcome drug resistance of ovarian cancers. Cancers. PMCID: PMC8582784.
• S. K. Singh, S. Singh, and R. Singh 2021. Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia. J Ovarian Res. PMCID: PMC8474883

Honors and Awards

• American Association of Immunologist (AAI)-Junior Faculty Travel Award, Laboratory Travel Grant, Amnis Travel Award, Trainee Award, and International Union of Immunological Societies (IUIS).
• American Association for Cancer Research (AACR)-Minority-serving Institution Faculty Scholar Award.
• National Institute of Health (NIH)- Certificate on Nanotechnology in Medicine.
• Department of Defense Prostate Cancer Research Program (CET-1, CET-2 and TRN-CET)-Peer Review Panel Member.
• Department of Defense Metabolic Disease (MD-1, Discovery Award)- Peer Review Panel Member.
• Department of Defense Ovarian Cancer Research Program, Immunology- Peer Review Panel Member
• Department of Defense Lung Cancer -Nanotechnology-Peer Review Panel Member.
• Department of Defense Ovarian Cancer, clinical development- Peer Review Panel Member.
• NIH/National Institute of General Medical Sciences (NIGMS)-SCORE-Peer Review Panel Member.
• NIH/National Institute of General Medical Sciences (NIGMS)-COBRE (P20)-Review Panel Member.
• NIH/National Cancer Institute (NCI)-Developmental Therapeutics Study Section (DT)- Peer Review Panel Member
• NIH Small Business: Innovative Immunology Research (IMM-M10) Study Section- Review Panel Member.
• National Science Foundation (NSF) Study Section.
• NIH/National Cancer Institute (NCI)-Cancer nanotechnology - Peer Review Panel Member.
• NHLBI Mentored Career Development to Promote Faculty Diversity in Research-Chair-Peer Review Panel Member.
• Cancer Research Wales Velindre Hospital Whitchurch Cardiff, UK Peer Review Panel Member.
• Nazarbayev University Research Review- Republic of Kazakhstan Peer Review Panel Member.
• National Science Center, Poland Peer Review Panel Member.
• Breast Cancer Foundation, New Zealand Peer Review Panel Member.